MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Immunosuppression"

  • 2025 International Congress

    Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS)

    MU. Huun, S. Wallace, SH. Nordstrand (Oslo, Norway)

    Objective: To report a rare case of anti-GAD associated encephalitis with pediatric Stiff Person Syndrome (SPS) highlighting the need for broad investigations and extensive treatment.…
  • 2025 International Congress

    Severe Anti-NMDAR Encephalitis After the Covid 19 Cross-vaccination in three young women

    K. Methawasin, P. Tungkiatsilp, C. Suthamdireklap, M. Jaisa-Aad (Nakhon Nayok, Thailand)

    Objective: To describe three severe cases of anti-NMDAR encephalitis in young females after the COVID-19 cross-vaccination. Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most recognized…
  • 2025 International Congress

    Early Impairment in the Immunomodulatory Function of Mesenchymal Stromal Cells Contributes to Heightened Peripheral and Neuroinflammation in Parkinson’s Disease Insights From In Vivo Chronic PD Rat Model and In Vitro PD iPSC Model

    R. Ghanty, I. Datta, G. Wagmare, N. Kamble, PK. Pal, V. Holla, R. Yadav, K. Mondal (Bengaluru, India)

    Objective: To assess the timeline dependent changes in endogenous Bone-Marrow-Mesenchymal-Stromal-Cells (BMMSC) in in-vivo chronic PD model and validating these cellular modifications in human iPSC derived…
  • 2024 International Congress

    GAD-Positive Versus GAD-Negative Stiff Person Syndrome: A Retrospective Study

    W. Khan, M. Hamed, H. Ooi, H. Sarva, M. Salgado, D. Victor (Doha, Qatar)

    Objective: Delineate demographic and clinical differences between GAD-65-antibody positive (seropositive) and negative (seronegative) SPS. Background: Elevated Glutamic Acid Decarboxylase 65 antibody (GAD-65 Ab) titers are…
  • 2024 International Congress

    Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

    P. Singh, A. Gupta, A. Gupta (Delhi, India)

    Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…
  • 2022 International Congress

    A longitudinal evaluation of the peripheral immune phenotype in a cohort of Parkinson’s disease patients

    L. Magistrelli, A. Furgiuele, E. Contaldi, M. Legnaro, E. Rasini, C. Comi, F. Marino, M. Cosentino (Novara, Italy)

    Objective: To evaluate the suitable modifications of immunological parameters in a through characterized population of Italian PD patientsTo evaluate the suitable modifications of immunological parameters…
  • MDS Virtual Congress 2021

    A Case of Autoimmune Orofacial Dyskinesia associated with Striational Antibody

    K. Kyle, G. Crotty, N. Venna (Boston, USA)

    Objective: This is a case of steroid-responsive, autoimmune orofacial dyskinesia associated with extremely elevated striational [striated muscle] antibody. We present this instructive case to add…
  • MDS Virtual Congress 2021

    IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY

    M. Bala, F. Gonzalez, M. Saucedo, L. Bandeo, A. Chertcoff, L. de Francesco, G. Napoli, L. Leon Cejas, P. Bonardo, N. Morera, L. Tschopp, C. Rugilo, C. Calandra, A. Pellene, G. Raina, Z. Salazar, G. Rinaldi, P. Judewicz, J. Rivas, J. Gustavo Jose, D. Ballesteros, M. Tela, F. Gualtieri, J. Amor, C. Esliman, F. Caiza Zambrano, T. Arakaki, N. Garretto, S. Rodriguez, A. Kohler, A. Laffue, O. Martinez, M. Fernandez Pardal, R. Reisin, C. Uribe Roca (Caba, Argentina)

    Objective: To evaluate the clinical characteristics, etiologies, treatment, and evolution of patients with immune-mediated movement disorders(IMMD). Background: The highly variable and complex phenomenology of IMMD and…
  • MDS Virtual Congress 2021

    Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial

    J. Greenland, E. Cutting, S. Kadyan, S. Bond, A. Chhabra, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To design a clinical trial to test the concept that the immune system is integral in the progression of Parkinson’s disease (PD) and establish…
  • MDS Virtual Congress 2021

    Tremor after organ transplantation: prevalence and characteristics

    A. Stouwe, J. Elting, D. Plasmeijer, S. Bakker, G. Drost (Groningen, Netherlands)

    Objective: Here we report on the largest population of solid organ transplant recipients that was investigated with clinical neurophysiological methods, to objectively establish the tremor…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley